Summary: Clinical studies demonstrate an overall favorable safety profile, low risk for hypoglycemia, weight neutrality, primarily nonrenal clearance, and efficacy for glycosylated hemoglobin reduction, typically ranging from 0.6% to 0.8% depending on baseline levels
2 Semaglutide, liraglutide, and tirzepatide have all shown cardiovascular protective effects, such as reducing lipid and blood pressure levels
[1] Tirzepatide is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis
the choice depends on your comfort level and lifestyle needs
It increases a teen's risk of type 2 diabetes, high blood pressure, fatty liver disease, sleep apnea, and joint problems
6 Conclusion Ferroptosis, a regulated form of cell death driven by iron accumulation and lipid peroxidation, has been increasingly recognized as a critical contributor to the pathogenesis and progression of Alzheimers disease (AD)